NCT00874939: A Study to Evaluate the Effects of MK-0249 and an Alzheimer's Disease Medication on Cognitive Function in Adults With Alzheimer's Disease (MK-0249-023) |
|
|
| Terminated | 1 | 4 | NA | MK-0249 7.5 mg, MK-0249 25 mg, Donepezil 5mg, Aricept, Placebo to MK-0249, Placebo to Donepezil | Merck Sharp & Dohme LLC | Alzheimer's Disease, Dementia | 04/09 | 04/09 | | |
